These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3910325)

  • 1. Lymphocyte proliferation as a test of the immune response to insulin in diabetics.
    Kurtz AB; Di Silvio L; Lydyard P
    Diabetes Res; 1985 Jul; 2(4):175-8. PubMed ID: 3910325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics.
    Nell LJ; Thomas JW
    J Immunol; 1983 Aug; 131(2):701-5. PubMed ID: 6190938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune alterations associated with human insulin therapy.
    Eichner HL; Lauritano AA; Woertz LL; Selam JL; Gupta S; Charles MA
    Diabetes Res; 1988 Jul; 8(3):111-5. PubMed ID: 3067952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
    Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
    Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative responses to insulin antigens in diabetics and controls.
    Scheinin T; Groop L; Nikkilä E; Kontiainen S
    J Clin Lab Immunol; 1983 Jul; 11(3):135-41. PubMed ID: 6350591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of human insulin on antibody formation in pregnant diabetics and their newborns.
    Chertow BS; Baranetsky NG; Sivitz WI; Swain PA; Grey J; Charles D
    Obstet Gynecol; 1988 Nov; 72(5):724-8. PubMed ID: 3050653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic allergy to human (recombinant DNA) insulin.
    Gossain VV; Rovner DR; Mohan K
    Ann Allergy; 1985 Aug; 55(2):116-8. PubMed ID: 3896050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin antibodies in the maternal and foetal circulation of pregnant diabetic women treated with human insulin of recombinant DNA origin.
    Leiper JM; Fineberg SE; Lunan CB; MacCuish AC
    Diabetes Res; 1984 Jul; 1(2):75-81. PubMed ID: 6397289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy.
    Grammer LC; Roberts M; Patterson R
    J Lab Clin Med; 1985 Jan; 105(1):108-13. PubMed ID: 3881543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune reactions caused by insulin].
    Velcovsky HG
    Fortschr Med; 1986 Jun; 104(21):431-4. PubMed ID: 3525358
    [No Abstract]   [Full Text] [Related]  

  • 16. [Purity and antigenicity of the new insulin preparations].
    Fankhauser S
    Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin binding to erythrocytes in insulin dependent diabetics with different insulin requirement and insulin antibody titre.
    Turco GL; Bruni B; Brossa C; D'Alberto M; Grassi G; Gamba Ansaldi S; Censon A
    J Nucl Med Allied Sci; 1984; 28(3):149-55. PubMed ID: 6397582
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin immunology: humoral and cellular aspects in mono-component insulin treated patients.
    Devlin JG; Maguire O; Parameswaran V; Blake PJ
    Postgrad Med J; 1979; 55 Suppl 2():14-8. PubMed ID: 482193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors affecting the antigenicity of exogenous insulin in diabetics].
    Penchev II; Taneva T; Ditsov S; Andreev D
    Vutr Boles; 1985; 24(1):113-9. PubMed ID: 3895740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.